Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery

NCT00838383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Surgery Subjects
Subjects Undergoing CABG and/or Cardiac Valve Replacement

Interventions

DRUG: sitaxsentan (Thelin)
DRUG: sitaxsentan (Thelin)
DRUG: Placebo

Sponsor

Pfizer